Urine Testing Cups Market Size, Share & Trends Analysis By Sterility (Sterile, Non-Sterile), By Product (With Temperature Strip, With Temperature Strip), By Application (Drug Testing, Pregnancy Testing), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Urine Testing Cups Market Summary

The surge in drug-related violations, as reported by the Drugs Control Administration (DCA) in Hyderabad, with 573 breaches in 2024 compared to just 56 in 2023, indicates a sharp rise in the circulation and abuse of illegal and spurious substances. This includes the seizure of narcotics worth over USD 1.3 million and the arrest of individuals, including medical professionals, involved in distributing psychoactive substances. These developments underscore the growing need for efficient, on-the-spot drug detection tools across healthcare, law enforcement, and workplace environments. As a result, the demand for urine testing cups, owing to their portability, rapid results, and ability to detect a wide range of illicit substances, is poised to rise significantly.

The significant global rise in drug use has majorly contributed to the growth of the market. For instance, according to the news published in June 2024 the World Drug Report 2024 reveals that the number of people who use drugs rose to 292 million in 2022, marking a 20% increase over the past decade, as shown in the graph below. This surge, driven by the widespread use of substances like synthetic opioids and cannabis, highlights the growing need for effective drug monitoring tools. Moreover, with an estimated 7 million individuals coming into formal contact with law enforcement for drug-related offences in 2022, there is a pressing demand for quick and reliable testing methods. The upward trend shown in the graph further supports this, emphasizing the critical role of urine testing cups in both healthcare and criminal justice settings to facilitate early detection, treatment, and prevention efforts.

According to data updated by the American Kidney Fund in February 2025, an estimated 35.5 million Americans are living with kidney disease, with nearly 555,000 undergoing dialysis and about 815,000 facing kidney failure. This sharp rise in chronic kidney conditions highlights the expanding use of urine testing in disease detection and long-term health monitoring. Urine testing cups offer a simple, non-invasive, and cost-effective method to detect early signs of kidney dysfunction, enabling timely medical intervention. As kidney disease now affects over 14% of American adults, disproportionately impacting people of color, the demand for regular screening tools like urine testing cups is increasing, making them vital in managing chronic health conditions and supporting preventive healthcare efforts.

Market Concentration & Characteristics

The market growth stage is moderate, and the pace of the market growth is accelerating. The urine testing cups market is characterized by growth owing to the rising prevalence of drug use globally and the increasing incidence of chronic conditions such as kidney disease. Increasing overall health awareness also boosts the use of urine testing cups for routine checkups. The demand for rapid, non-invasive, and cost-effective diagnostic tools fuels widespread adoption across healthcare and other sectors.

The urine testing cups market is experiencing notable innovation, with companies such as Advin Biotech and Premier Biotech introducing advanced features to enhance functionality and efficiency. Advin Biotech’s POCiT cup includes an integrated vessel that preserves a clean, removable specimen for confirmation testing or regulatory compliance, making it especially valuable in high-volume settings such as pain labs by reducing processing time. Meanwhile, Premier Biotech offers a portfolio of rapid, integrated test cups that prioritize accuracy, speed, ease of use, and customizable drug panels. These advancements reflect a strong focus on improving user experience, compliance, and adaptability, underscoring the market’s commitment to next-generation diagnostic solutions.

Regulatory agencies such as the Food and Drug Administration (FDA), Health Canada, the European Union, and other bodies establish quality and safety standards for medical devices, including urine testing cups products. These devices are classified into different categories based on the associated risk levels, with regulatory scrutiny varying accordingly.

The urine testing cups market has seen a moderate level of mergers and acquisitions, driven by the need for expanded product portfolios and technological capabilities. Companies are strategically aligning to enhance distribution networks and enter new regional markets. These consolidations support innovation while maintaining competitive pricing and compliance with evolving healthcare regulations.

Product substitutes for urine testing cups include urine test strips, disposable urine bags, and emerging innovative diagnostic tools. Urine test strips offer quick and cost-effective analysis of various parameters such as glucose and protein, often used with separate collection containers. Disposable urine bags, designed for leak-proof and hygienic collection, are especially useful in travel or remote care settings. Smart diagnostic devices, including smartphone-based readers and toilet-integrated sensors, are also gaining traction for providing real-time, user-friendly urine analysis at home. These alternatives offer convenience, privacy, and advanced functionality, posing growing competition to traditional urine testing cups.

Regional expansion in the urine testing cups market is actively driven by strategic investments and collaborations to address global healthcare challenges. For instance, in March 2024, Toyoda Gosei Co., Ltd. invested in Yuurea, Inc., a company developing simple urine-based test kits for personal health monitoring. This move reflects a growing commitment to preventive medicine and highlights the increasing interest of major corporations in expanding their presence in the healthcare sector. By promoting the adoption of such technologies across their networks, including employees and business partners, companies such as Toyoda Gosei are fostering the regional growth and acceptance of urine testing solutions, including urine testing cups.

Sterility Insights

Sterile urine testing cups dominated the market with a revenue share of 79.54% due to their critical role in ensuring sample integrity, accuracy, and safety across medical and forensic applications. These cups are designed to prevent contamination, making them essential for diagnostic testing, drug screening, and disease monitoring where precise results are vital. Their widespread use in hospitals, diagnostic labs, and law enforcement settings reflects growing regulatory emphasis on hygiene and reliability. As healthcare providers increasingly prioritize infection control and accurate diagnostics, the demand for sterile urine testing cups continues to outpace their non-sterile counterparts.

Non-sterile urine testing cups are expected to witness growth in the coming years due to their cost-effectiveness and suitability for low-risk or preliminary testing environments. They are increasingly used in workplace drug testing, educational institutions, and at-home health monitoring where sterility is less critical. Rising awareness and accessibility of self-testing options are also contributing to their growing demand.

Product Insights

Urine testing cups with temperature strips held the largest market in 2024, due to their enhanced ability to ensure sample authenticity and reliability. The integrated temperature strip helps verify whether a urine sample is freshly collected, a critical factor in drug screening and forensic testing where sample tampering is a concern. These cups are widely preferred in clinical, workplace, and law enforcement settings for their added layer of verification, which supports compliance with regulatory standards. As the demand for accurate and trustworthy testing continues to rise, products with built-in temperature validation remain the preferred choice across various sectors.

Furthermore, urine testing cups without temperature strips are gaining traction due to their affordability and suitability for non-critical testing environments. They are ideal for use in educational institutions, home testing, and wellness programs where strict verification protocols are not required. The simplicity and lower cost make them attractive for bulk screening initiatives. In addition, rising awareness of preventive healthcare is boosting their adoption in routine health monitoring.

Application Insights

The drug testing segment dominated the application landscape in the urine testing cups market in 2024, driven by the widespread use of multi-drug test cups such as the iScreen, iCup, and E-Z Split Key. These all-in-one screening tools are highly efficient in detecting multiple substances, including amphetamines, cocaine, marijuana, opiates, and fentanyl from a single urine sample. Their convenience, reliability, and broad detection capabilities make them indispensable in workplaces, law enforcement, rehabilitation centers, and healthcare settings. As the need for rapid and accurate drug screening continues to grow, especially in response to rising substance abuse, this segment maintains a strong lead in market demand.

The disease detection segment is projected to grow at the fastest CAGR in the urine testing cups market, fueled by advancements in medical diagnostics and increasing demand for early, non-invasive testing methods. As highlighted by Urteste S.A.'s development of a prototype IVD test capable of detecting brain tumors from urine samples, the scope of urinalysis is expanding far beyond traditional uses. A pipeline of 12 diagnostic tests targeting major cancers responsible for nearly 70% of global cancer deaths, urine-based testing is emerging as a powerful tool in oncology and chronic disease management. This trend reflects a broader shift toward preventive healthcare and the rising adoption of urine testing cups to detect serious health conditions, including kidney disease, diabetes, and liver disorders.

End-use Insights

The hospital and clinics segment held the largest share in 2024, driven by the high volume of diagnostic and drug screening procedures conducted in these settings. Urine testing cups are essential tools in hospitals and clinics for routine health checkups, disease detection, pre-surgical assessments, and monitoring of chronic conditions. They are widely used for pregnancy testing, helping clinicians make timely and accurate diagnoses. Their ability to deliver quick and precise results makes them a preferred patient choice. Moreover, the increasing patient load and growing emphasis on early diagnosis and preventive care further solidify the strong demand for urine testing cups. 

The home use segment is expected to grow the fastest in the coming years, driven by technological innovations that bring clinical-grade testing to home settings. A prime example is the URINE CHECK-ER, the world’s first cup-type urine analyzer, recently recognized at the CES Innovation Awards 2025. This device revolutionizes at-home urinalysis by replacing traditional, unsanitary strip-type tests with a user-friendly, app-connected solution that offers medical institution-level accuracy. Its ability to digitize and store results for telemedicine or clinical follow-up makes it particularly valuable for individuals in remote or underserved regions, reflecting a broader shift toward decentralized and accessible healthcare solutions. 

Regional Insights

North America urine testing cups market held the largest revenue share of more than 38.95% in 2024. The urine testing cups market in North America is driven by increasing research and innovation focused on early disease detection through non-invasive methods. For instance, according to the news published in October 2024, new studies from leading institutions such as The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford University have demonstrated that urine analysis, specifically the examination of RNA and other cellular substances, can reveal early signs of diseases such as cancer affecting the genitourinary tract. Combined with rising concerns over drug use and a growing emphasis on preventive healthcare, these advancements significantly boost the demand for advanced urine testing solutions across the region.

U.S. Urine Testing Cups Market Trends

The presence of prominent U.S.-based companies such as Thermo Fisher Scientific and Premier Biotech, Inc. is a significant driving factor for the urine testing cups market in the country. These industry leaders are continuously advancing product innovation, expanding testing capabilities, and improving distribution networks. Their strong R&D investments and commitment to regulatory compliance ensure the availability of high-quality, reliable testing solutions, further fueling market growth across clinical, workplace, and home-use applications in the U.S.

Europe Urine Testing Cups Market Trends

The urine testing cups market in Europe is significantly driven by the rising burden of Chronic Kidney Diseases (CKD), particularly in countries like the UK. According to the Economics-of-Kidney-Disease report published in June 2023, approximately 7.2 million people in the UK, over 10% of the population, live with various CKD stages. This growing prevalence underscores the urgent need for regular and accessible diagnostic tools for early detection and monitoring. As non-invasive and cost-effective, urine testing cups are increasingly utilized in clinical and home settings to support kidney health management, contributing to the market’s expansion across Europe.

The urine testing cups market in UK is being driven by the rising prevalence of drug use, particularly among adults. According to the Crime Survey for England and Wales (CSEW), an estimated 1.8% of people aged 16 to 59, approximately 610,000 individuals, were frequent drug users in the year ending March 2024. This growing concern around substance abuse is prompting increased demand for efficient, accurate, and rapid drug screening tools. As a result, urine testing cups are becoming essential in workplace testing, law enforcement, and healthcare settings, supporting broader public health and safety initiatives across the country.

France urine testing cups market is projected to grow during the forecast period, driven by the increasing emphasis on preventive healthcare and routine medical screening. With rising public awareness of chronic diseases such as diabetes and kidney disorders, there is a growing demand for non-invasive, rapid diagnostic tools in both clinical and home settings. Government initiatives promoting regular health checkups and early detection programs further support the adoption of urine testing cups across the country.

The urine testing cups market in Germany is witnessing steady growth due to various factors, such as its strong healthcare infrastructure and the growing need for workplace drug testing and chronic disease monitoring. As one of Europe’s largest healthcare markets, Germany is witnessing increased utilization of urine-based diagnostics for conditions such as urinary tract infections, kidney disease, and diabetes. Additionally, the rise in substance use awareness and regulatory compliance in employment sectors is contributing to the growing demand for reliable and efficient urine testing solutions.

Asia Pacific Urine Testing Cups Market Trends

The Asia Pacific region is expected to register the highest CAGR during the forecast period, driven by significant growth in the urine testing cups industry. Key factors include rising demand for urine testing cups products in Southeast Asian countries such as Indonesia, Malaysia, and Singapore. In addition, increasing healthcare expenditure in Singapore and Malaysia is expected to further boost market growth in the region. Moreover, the large patient population in countries such as India, China and Japan can further propel the market growth over the forecast period.

The urine testing cups market in China is driven by several key factors, including the growing demand for rapid and reliable diagnostic tools in healthcare, workplace drug testing, and law enforcement. Chinese manufacturers, such as Safecare Biotech and those producing for international brands like Abbott Toxicology’s iSCREEN, are capitalizing on the increasing global need for cost-effective and scalable drug screening solutions. In addition, China’s strong manufacturing infrastructure, government support for medical device exports, and the rising prevalence of substance abuse testing in both domestic and international markets contribute to the expansion of this sector.

The Japan urine testing cups market is being driven by innovations aimed at improving clinical efficiency, safety, and reliability in diagnostic procedures. A key example is the introduction of TUBYCON-U, an all-in-one urine test cup designed with input from medical professionals. This device integrates a container and detachable tube, reduces the risk of sample mix-ups with pre-attached barcodes, and features a needle-free design that cuts medical waste disposal costs. Such advancements enhance the working conditions for medical staff and elevate patient safety, reflecting Japan’s broader focus on precision, automation, and healthcare quality key factors propelling market growth in the region.

Latin America Urine Testing Cups Market Trends

The urine testing cups market in Latin America is growing steadily, fueled by rising concerns over drug abuse and the need for efficient screening tools across multiple sectors. Increasing enforcement of drug policies in workplaces, expanding healthcare access, and mandatory testing in competitive sports are key contributors to this demand. Furthermore, advancements in rapid diagnostic technologies and supportive government health initiatives are making urine-based testing more accessible and widely adopted throughout the region

The urine testing cups market in Brazil is expanding due to several key factors. Mandatory drug testing in sports to uphold fair play and athlete health further drives demand for reliable testing solutions. In addition, government initiatives aimed at controlling drug-related issues, coupled with advancements in point-of-care testing technologies, are enhancing the efficiency and accuracy of drug screening programs, contributing to the market's growth.

Middle East and Africa Urine Testing Cups Market Trends

The Middle East and Africa urine testing cups market is expanding due to several key factors. The rising prevalence of substance abuse, particularly opioids and illicit drugs, has heightened the need for effective drug screening methods across workplaces, healthcare institutions, and law enforcement agencies. Government initiatives aimed at controlling drug-related issues, coupled with stringent workplace safety regulations, are further propelling the demand for reliable and rapid diagnostic tools. In addition, technological advancements in point-of-care testing devices and the integration of innovative screening methods are enhancing the efficiency and accuracy of drug testing programs, contributing to the market's growth.

The Saudi Arabia urine testing cups market is growing rapidly due to strict anti-drug laws, increased workplace safety regulations, and government initiatives under Vision 2030 to combat drug abuse. Rising drug-related concerns and the need for efficient, on-the-spot testing solutions across sectors such as law enforcement, healthcare, and industry are further driving demand for reliable and rapid diagnostic tools.

The urine testing cups market in Kuwait is experiencing growth driven by several key factors. The increasing prevalence of substance abuse has heightened the need for effective drug screening methods, prompting both public and private sectors to adopt urine testing cups for workplace and clinical diagnostics. Government regulations mandating drug testing in safety-sensitive industries further bolster this demand. In addition, the expansion of healthcare infrastructure and the adoption of point-of-care testing technologies contribute to the market's upward trajectory.

Key Urine Testing Cups Company Insights

BD, Abbott Toxicology, Labcon North America, Quest Diagnostics, Co-Innovation Biotech Co., Ltd., Alfa Scientific Designs, Inc.MEDLINE, GLOBE SCIENTIFIC INC, CLIAWAIVED, CLARITY DIAGNOSTICS, SARSTEDT INC and WONDFO. are some of the major players in the urine testing cups market. Companies are expanding their portfolios of urine testing cups devices, to gain a competitive advantage in the coming years.

Recent Developments

• In September 2024, PreAnalytiX, a joint venture between QIAGEN and BD, has launched the PAXgene Urine Liquid Biopsy Set, enabling non-invasive urine sample collection and immediate stabilization of cell-free DNA. This innovative solution includes a collection cup and a nucleic acid stabilizing tube, advancing liquid biopsy capabilities. 

Urine Testing Cups Market Report Scope 

Global Urine Testing Cup Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global urine testing cups market report on the basis of sterility, product, application, end-use, and region:

• Sterility Outlook (Revenue, USD Million, 2018 - 2030)

  • Sterile

  • Non- Sterile

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • With Temperature Strip

  • Without Temperature Strip

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Drug Testing

  • Pregnancy Testing

  • Disease Detection

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics

  • Diagnostic Laboratories

  • Home Use

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait